Mass General Psychiatry: Adult Outpatient Psychiatry Services
55 Fruit St.
Wang Ambulatory Care Center
Boston, MA 02114
- PhD, George Mason University
- Residency, Massachusetts General Hospital
Accepted Insurance Plans
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Weingarden's research interests are broadly focused on cognitive and emotional risk factors for poor psychosocial outcomes in individuals with obsessive-compulsive related disorders (OCRDs) and body image disturbances. She is particularly interested in the roles of shame and other non-anxiety emotions (e.g., disgust, guilt) in OCRDs. Dr. Weingarden is also interested in issues of access to empirically supported treatments and how technology may be used to improve treatment access.
For more details about my research, please visit my website.
Selected recent publications:
Weingarden H, Hoeppner SS, Snorrason I, Greenberg JL, Phillips KA, Wilhelm S (in press). Rates of remission, sustained remission, and recurrence in a randomized controlled trial of cognitive behavioral therapy versus supportive psychotherapy for body dysmorphic disorder. Depression & Anxiety.
Weingarden H, Matic A, Garriga Calleja R, Greenberg JL, Harrison O, Wilhelm S (2020). Optimizing smartphone cognitive behavioral therapy for body dysmorphic disorder using passive smartphone data: Initial insights from a pilot trial. JMIR mHealth & uHealth.
Wilhelm S, Weingarden H, Ladis I, Braddick V, Shin J, Jacobson NC (2020). Cognitive-behavioral therapy in the digital age: Presidential Address. Behavior Therapy, 51(1), 1-14.
Wilhelm S, Weingarden H, Greenberg J, Ladis I, McCoy T, Summers B, Matic A, Harrison O. (2020). Development and pilot testing of smartphone-delivered cognitive behavioral therapy for body dysmorphic disorder: Preliminary feasibility, acceptability, and efficacy. Behavior Therapy, 51, 15-26.
†Greenberg JL, †Weingarden H, Wilhelm S. (2019). A practical guide to managing body dysmorphic disorder in the cosmetic surgery setting. JAMA Facial Plastic Surgery, 21, 181-182.
Jacobson NC, Weingarden H, Wilhelm S. (2019). Digital biomarkers of mood disorders and symptom change. npj Digital Medicine, 2, 3.